25 April 2018 EMA/381051/2018 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: finasteride

Procedure no.: PSUSA/00001392/201708

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised AT

number Proscar 5 mg Filmtabletten Propecia 1 mg Filmtabletten PROSCAR® 5 mg, Filmtabletten PROSCAR® 5 mg, comprimés pelliculés PROSCAR® 5 mg, filmomhulde tabletten PROPECIA 1 mg, filmcoated tablets PROPECIA® potahované tablety PROSCAR°5 mg Filmtabletten Wirkstoff: Finasterid Zur Anwendung bei männlichen Patienten PROPECIA® 1 mg Filmtabletten Propecia, filmovertrukne tabletter PROSCAR 5 mg comprimidos recubiertos con película Propecia 1 mg comprimidos recubiertos con película Proscar 5 mg filmdragerade tabletter PROSCAR 5 mg tabletti, kalvopäällysteinen Propecia 1 mg filmdragerade tabletter Propecia 1 mg tabletti, kalvopäällysteinen

not available

1-19689

SE/H/0158/001

1-24532

not available

BE160124

MERCK SHARP & DOHME GES.M.B.H. MERCK SHARP & DOHME GES.M.B.H. MSD BELGIUM BVBA/SPRL

not available

BE160124

MSD BELGIUM BVBA/SPRL

BE

not available

BE160124

MSD BELGIUM BVBA/SPRL

BE

not available

18318

MERCK SHARP & DOHME BV

CY

not available

87/244/99-C

MERCK SHARP & DOHME BV

CZ

not available

42859.00.00

MSD SHARP & DOHME GMBH

DE

SE/H/0158/001

44270.00.00

MSD SHARP & DOHME GMBH

DE

SE/H/0158/001

30252

MERCK SHARP & DOHME BV

DK

not available

59.830

LABORATORIOS CHIBRET, S.A.

ES

SE/H/0158/001

62.441

MERCK SHARP & DOHME DE ESPAÑA, S.A

ES

not available

10751

MERCK SHARP & DOHME BV

FI

not available

10751

MERCK SHARP & DOHME BV

FI

SE/H/0158/001

13713

MERCK SHARP & DOHME BV

FI

SE/H/0158/001

13713

MERCK SHARP & DOHME BV

FI

List of nationally authorised medicinal products EMA/381051/2018

AT BE

Page 2/8

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé Propecia 1 mg, comprimé pelliculé Propecia 1 mg, comprimé pelliculé Propecia 1 mg, comprimé pelliculé Propecia 1 mg, comprimé pelliculé Propecia 1 mg, comprimé pelliculé PROPECIA 1mg, επικαλυμμένα με λεπτό υμένιο δισκία PROSCAR επικαλυμμένο με λεπτό υμένιο δισκίο 5mg/TAB PROSCAR® 5 mg filmom obložene tablete PROSCAR 5 mg filmcoated tablets

not available

34009 335 248 4 5

MSD FRANCE

FR

not available

34009 379 090 7 5

MSD FRANCE

FR

not available

34009 379 091 3 6

MSD FRANCE

FR

not available

34009 335 688 4 9

MSD FRANCE

FR

not available

34009 335 249 0 6

MSD FRANCE

FR

not available

34009 335 690 9 9

MSD FRANCE

FR

not available

34009 335 689 0 0

MSD FRANCE

FR

not available

34009 335 691 5 0

MSD FRANCE

FR

SE/H/0158/001

34009 349 065 4 1

MSD FRANCE

FR

SE/H/0158/001

34009 349 070 8 1

MSD FRANCE

FR

SE/H/0158/001

34009 349 066 0 2

MSD FRANCE

FR

SE/H/0158/001

34009 349 068 3 1

MSD FRANCE

FR

SE/H/0158/001

34009 349 067 7 0

MSD FRANCE

FR

SE/H/158/01/R02

52369/30-06-2016

VIANEX S.A.

GR

not available

21729/14-11-2014

VIANEX S.A.

GR

not available

HR-H-039526411

HR

not available

PA 1286/17/1

MERCK SHARP & DOHME D.O.O. MERCK SHARP & DOHME IRELAND (HUMAN HEALTH) LTD

List of nationally authorised medicinal products EMA/381051/2018

IE

Page 3/8

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Propecia 1 mg filmuhúðaðar töflur PROSTIDE 5 mg compresse rivestite con film PROSTIDE 5 mg compresse rivestite con film Finasteride AHCL 1 mg compresse rivestite con film Finasteride AHCL 1 mg compresse rivestite con film Finasteride AHCL 1 mg compresse rivestite con film Finasteride AHCL 1 mg compresse rivestite con film Pilus 1mg compressa rivestita con film Pilus 1mg compressa rivestita con film Pilus 1mg compressa rivestita con film Pilus 1mg compressa rivestita con film PILUS 1mg compressa rivestita con film Finasteride AHCL 1 mg compresse rivestite con film Finasteride AHCL 1 mg compresse rivestite con film

SE/H/0158/001

IS/1/02/010/01

MERCK SHARP & DOHME BV

IS

not available

028356018

ALFASIGMA S.P.A.

IT

not available

028356020

ALFASIGMA S.P.A.

IT

NL/H/1149/001

039595020

ACCORD HEALTHCARE LIMITED

IT

NL/H/1149/001

039595184

ACCORD HEALTHCARE LIMITED

IT

NL/H/1149/001

039595196

ACCORD HEALTHCARE LIMITED

IT

NL/H/1149/001

039595018

ACCORD HEALTHCARE LIMITED

IT

not available

034824019

IT

not available

034824033

not available

034824045

not available

034824058

not available

034824021

NL/H/1149/001

039595020

NEOPHARMED GENTILI S.R.L. NEOPHARMED GENTILI S.R.L. NEOPHARMED GENTILI S.R.L. NEOPHARMED GENTILI S.R.L. NEOPHARMED GENTILI S.R.L. ACCORD HEALTHCARE LIMITED

NL/H/1149/001

039595184

ACCORD HEALTHCARE LIMITED

IT

List of nationally authorised medicinal products EMA/381051/2018

IT IT IT IT IT

Page 4/8

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Finasteride AHCL 1 mg compresse rivestite con film Finasteride AHCL 1 mg compresse rivestite con film PROSCAR 5 mg compresse rivestite con film PROSCAR 5 mg compresse rivestite con film Propecia 1 mg compresse rivestite con film Propecia 1 mg compresse rivestite con film Propecia 1 mg compresse rivestite con film Propecia 1 mg compresse rivestite con film Propecia 1 mg compresse rivestite con film Finasteride Teva Generics 1 mg compresse rivestite con film Finasteride Teva Generics 1 mg compresse rivestite con film

NL/H/1149/001

039595196

ACCORD HEALTHCARE LIMITED

IT

NL/H/1149/001

039595018

ACCORD HEALTHCARE LIMITED

IT

not available

028308017

MERCK SHARP & DOHME LTD.

IT

not available

028308029

MERCK SHARP & DOHME LTD.

IT

SE/H/0158/001

034237014

MSD ITALIA S.R.L.

IT

SE/H/0158/001

034237038

MSD ITALIA S.R.L.

IT

SE/H/0158/001

034237040

MSD ITALIA S.R.L.

IT

SE/H/0158/001

034237053

MSD ITALIA S.R.L.

IT

SE/H/0158/001

034237026

MSD ITALIA S.R.L.

IT

UK/H/4251/001

040952057

TEVA ITALIA S.R.L.

IT

UK/H/4251/001

040952020

TEVA ITALIA S.R.L.

IT

List of nationally authorised medicinal products EMA/381051/2018

Page 5/8

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Finasteride Teva Generics 1 mg compresse rivestite con film Finasteride Teva Generics 1 mg compresse rivestite con film Finasteride Teva Generics 1 mg compresse rivestite con film Finasteride Teva Generics 1 mg compresse rivestite con film FINASTID 5 mg compresse rivestite con film FINASTID 5 mg compresse rivestite con film GENAPROST 5 mg compresse rivestite con film GENAPROST 5 mg compresse rivestite con film PROSCAR® 5 mg, comprimés pelliculés Propecia 1 mg, comprimé pelliculé Finasteride Accord 1 mg apvalkotās tabletes Finasteride Accord 1 mg apvalkotās tabletes

UK/H/4251/001

040952071

TEVA ITALIA S.R.L.

IT

UK/H/4251/001

040952032

TEVA ITALIA S.R.L.

IT

UK/H/4251/001

040952044

TEVA ITALIA S.R.L.

IT

UK/H/4251/001

040952069

TEVA ITALIA S.R.L.

IT

not available

028309019

NEOPHARMED GENTILI S.R.L.

IT

not available

028309021

NEOPHARMED GENTILI S.R.L.

IT

not available

028371019

NEOPHARMED GENTILI S.R.L.

IT

not available

028371021

NEOPHARMED GENTILI S.R.L.

IT

not available

2003107721

MSD BELGIUM BVBA/SPRL

LU

SE/H/0158/001

2009030231

MSD BELGIUM BVBA/SPRL

LU

NL/H/1149/001

09-0154

LV

NL/H/1149/001

09-0154

ACCORD HEALTHCARE LIMITED ACCORD HEALTHCARE LIMITED

List of nationally authorised medicinal products EMA/381051/2018

LV

Page 6/8

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number PROSCAR® 5mg filmcoated Tablets (finasteride) PROPECIA 1 mg FilmCoated Tablets PROSCAR 5 mg, filmomhulde tabletten Propecia 1 mg, filmomhulde tabletten Proscar 5 mg tabletter PROPECIA 1 mg, tabletki powlekane PROSCAR, 5 mg, tabletki powlekane Proscar 5 mg comprimidos revestidos por película Proscar 5 mg comprimidos revestidos por película Proscar 5 mg comprimidos revestidos por película Propecia 1 mg comprimidos revestidos por película Propecia 1 mg comprimidos revestidos por película Propecia 1 mg comprimidos revestidos por película Propecia 1 mg comprimidos revestidos por película

not available

MA 058/00701

MERCK SHARP & DOHME LTD.

MT

not available

MA058/00801

MT

not available

RVG 15482

MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME BV

SE/H/0158/001

RVG 27397

MERCK SHARP & DOHME BV

NL

not available not available

7841 4602

MERCK SHARP & DOHME BV MSD POLSKA SP. Z O.O.

NO PL

not available

R/3621

MSD POLSKA SP. Z O.O.

PL

not available

2133189

MERCK SHARP & DOHME, LDA.

PT

not available

2133288

MERCK SHARP & DOHME, LDA.

PT

not available

2133387

MERCK SHARP & DOHME, LDA.

PT

SE/H/0158/001

2832988

MERCK SHARP & DOHME, LDA.

PT

SE/H/0158/001

2832780

MERCK SHARP & DOHME, LDA.

PT

SE/H/0158/001

2832889

MERCK SHARP & DOHME, LDA.

PT

SE/H/0158/001

2832582

MERCK SHARP & DOHME, LDA.

PT

List of nationally authorised medicinal products EMA/381051/2018

NL

Page 7/8

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Propecia 1 mg comprimidos revestidos por película Propecia 1 mg comprimate filmate PROSCAR 5 mg comprimate filmate PROSCAR 5 mg comprimate filmate PROPECIA 1 mg filmdragerad tablett Proscar 5 mg filmdragerad tablett Prostide 5 mg filmsko obložene tablete

SE/H/0158/001

2832681

MERCK SHARP & DOHME, LDA.

PT

not available

9711/2017/01

& DOHME

RO

not available

5885/2013/01

& DOHME

RO

not available

5885/2013/02

& DOHME

RO

SE/H/0158/001

13483

MERCK SHARP ROMANIA SRL MERCK SHARP ROMANIA SRL MERCK SHARP ROMANIA SRL MERCK SHARP

& DOHME BV

SE

not available

11644

MERCK SHARP & DOHME BV

SE

not available

H/97/01301/001

SI

Propecia 1 mg filmsko obložene tablete

not available

H/99/01294/001

Finasteride 5 mg filmcoated tablets Finasteride 5mg Tablets PROSCAR® 5mg filmcoated Tablets (finasteride) Propecia® 1 mg FilmCoated Tablets Finasteride 1 mg Filmcoated Tablets

not available

PL 21880/0052

MERCK SHARP & DOHME INOVATIVNA ZDRAVILA D.O.O. MERCK SHARP & DOHME INOVATIVNA ZDRAVILA D.O.O. MEDREICH PLC

AT/H/0268/001 not available

PL 04416/0816 PL 0025/0279

SANDOZ LTD MERCK SHARP & DOHME LTD.

UK UK

not available

PL 0025/0351

UK

UK/H/4251/001

PL 00289/0826

MERCK SHARP & DOHME LTD. TEVA UK LIMITED

List of nationally authorised medicinal products EMA/381051/2018

SI UK

UK

Page 8/8

Finasteride - European Medicines Agency - europa.eu

Apr 25, 2018 - Page 2/8. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the.

140KB Sizes 1 Downloads 347 Views

Recommend Documents

Finasteride - European Medicines Agency - Europa EU
Apr 20, 2017 - Send a question via our website www.ema.europa.eu/contact ... Product full name ... FINASTERIDE 5 mg Film-coated tablets not available.

Notice - European Medicines Agency
Apr 28, 2017 - 2. The United Kingdom will then become a 'third country'. 3. Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties. In view of the considerable uncertainties, in parti

Report - European Medicines Agency
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.

Human Medicines Highlights Newsletter - European Medicines Agency
Mar 8, 2018 - Treatment of uterine fibroids. Haematology. New medicines authorised. • Adynovi (rurioctocog alfa pegol). Treatment and prevention of bleeding in patients with haemophilia A. New information on authorised medicines. • Feraccru (ferr

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Treatment of cystine crystal deposits in the eye. New information on authorised medicines. Lucentis (ranibizumab) - change in indication. Treatment of visual ...

Human Medicines Highlights Newsletter - European Medicines Agency
The new EudraVigilance system and the electronic reporting of individual case ... the ISO/ICH E2B(R3) format: hands-on training course - October 2017 ... granted a conditional marketing authorisation on the basis of less complete clinical data ...

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Agenda - European Medicines Agency - europa.eu
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

Human medicines highlights newsletter - European Medicines Agency
PCWP and HCPWP joint meeting - Sept 2016 - meeting documents. • Workshop on identifying opportunities for 'big data' in medicines development and ...

Human Medicines Highlights Newsletter - European Medicines Agency
Used for the management of hypovolaemia (low blood volume) caused by acute (sudden) blood loss .... EMA's Business Continuity Plan for Brexit published.

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a ... Withdrawal of applications for new medicines .... fifth annual regulatory conference on optimising the development of advanced therapies to.

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Implant used to help new bone develop in patients with spinal disc problems and leg fractures .... E-mail [email protected] Website www.ema.europa.eu.

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a desktop news reader. For a list of RSS readers please refer to ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

Agenda - European Medicines Agency - europa.eu
Jun 18, 2018 - 27. 7.8.1. List of all applications submitted/expected and the COMP coordinatorship distribution of .... 5,10-dihydrodibenzo[b,e][1,4] diazepin-11-one, EMA/OD/031/10 Glutathione-pegylated ...... Abbreviations / Acronyms.

Committee_Meeting dates_2017 - European Medicines Agency
Sep 26, 2016 - An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

dexlansoprazole, lansoprazole - European Medicines Agency
European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged. 13 September 2017. EMA/727763/2017. Human Medicines Evaluation Division. List of nationally authorised medicinal products. Active substance(s): dexlansop

monthly figures - December 2016 - European Medicines Agency
Jan 10, 2017 - Applicants can request a re-examination. The first four rows present the outcome of the evaluation before a re-examination (or a.

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.